Similarly, in a mouse model, subcutaneous administration of 100 μg/kg/day of G-CSF for a period of 5 days after acute myocardial infarction, significantly improved post-MI survival and reduced ischemic cardiomyopathy. The gene discussed is CSF3; the disease is myocardial infarction.